PTPA and Parkinson disease: Increase the level of BDNF; Own neuroprotective effects; Protect against neuroinflammatory cell death; Stimulates PP2A to enhance the activity of α-syn; Reduce PD progression by inhibiting NLRP3 inflammasome activation; Abolish the loss of TH immunoreactivity.